Page 1

August 5 , 2021 stratasys Stratasys Releases Second Quarter 2021 Financial Results • Revenue of $ 147.0 million • GAAP net loss of $ 20.2 million , or $ 0.31 per diluted share , and non - GAAP net loss of $ 1.6 million , or $ 0.02 per diluted share • Generated $ 5.6 million of cash from operations • Furthering penetration into Healthcare - introduced J5 MediJet medical 3D printer • $ 522.7 million cash and equivalents and no debt at quarter end MINNEAPOLIS & REHOVOT , Israel -- ( BUSINESS WIRE ) -- Stratasys Ltd. ( NASDAQ : SSYS ) announced financial results for the second quarter of 2021 . Second Quarter 2021 Financial Results Summary Compared to Second Quarter 2020 : • Revenue of $ 147.0 million compared to $ 117.6 million . • GAAP gross margin was 43.0 % , compared to 37.2 % . • Non - GAAP gross margin was 47.5 % , compared to 45.4 % . • GAAP operating loss was $ 22.7 million , compared to an operating loss of $ 29.3 million . • Non - GAAP operating loss was $ 2.6 million , compared to an operating loss of $ 8.1 million . • GAAP net loss was $ 20.2 million , or $ 0.31 per diluted share , compared to a net loss of $ 28.0 million , or $ 0.51 per diluted share . • Non - GAAP net loss was $ 1.6 million , or $ 0.02 per diluted share , compared to a net loss of $ 7.4 million , or $ 0.13 per diluted share . • Adjusted EBITDA was $ 3.5 million , compared to $ ( 1.6 ) million . • Cash provided by operations of $ 5.6 million , compared to cash use of $ 9.7 million . Dr. Yoav Zeif , Stratasys's Chief Executive Officer stated , “ Our strong second quarter results were highlighted by a 25 % year over year revenue improvement with growth from all regions and all business lines . Our focus on manufacturing gained further traction , we increased the monetization and ecosystem partnerships of our software business , and we expanded our medical and dental offerings , advancing our plans for further penetration in the healthcare industry . " Dr. Zeif continued , “ The transition of the 3D printing industry from prototyping to mass production is ongoing , and our commitment to being the first choice in polymer 3D printing positions us to be the main benefactor . We are investing across technology , software , materials , and talent to capture increased market share that we expect will yield significant returns and sustained profitability in the years to come . " Financial Outlook : ( TBD )